Albuminuria

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
A Gastroenterology (ATC A) 1
C Cardiology (ATC C) 1
Mechanism of action (INN-stem analysis)
SGLT2 inhibitor 1 substance
Unknown / small molecule 1 substance
Phase IV: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase IV

1 trial
  • Universitair Medisch Centrum Groningen Academic
    EMPAGLIFLOZIN; FINERENONE
    2023-508585-15-00 1 country 2024 n=10
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Universitair Medisch Centrum Groningen Academic 1 Phase IV 0
New trials by year
2024
1
← All indication landscapes